Globus Medical, Inc. Class A (GMED) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Globus Medical, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.460 Welcome to Globus Medical's fourth quarter and full year 2025 earnings 00:00:05.460 -- 00:00:10.488 call. At this time, all lines will be on mute, and a question and 00:00:10.488 -- 00:00:13.693 answer session will be held after the prepared remarks. 00:00:13.693 -- 00:00:17.078 I will now turn the call over to Brian Kern, 00:00:17.078 -- 00:00:20.684 Senior Vice President of Business Development and Investor Relations. 00:00:20.684 -- 00:00:23.846 Mr. Kern, please go ahead. 00:00:24.290 -- 00:00:27.942 Thank you, Dana, and thank you, everyone, for being with us today. 00:00:27.942 -- 00:00:33.328 Joining today's call from Globus Medical will be Keith Feil, President and CEO, 00:00:33.328 -- 00:00:36.632 and Kyle Klein, Chief Financial Officer. 00:00:36.632 -- 00:00:41.337 This review is being made available via webcast accessible through the investor relations 00:00:41.337 -- 00:00:46.101 section of the Globus Medical website at www.globusmedical.com. 00:00:48.065 -- 00:00:52.931 Before we begin, let me remind you that some of the statements made during this review 00:00:52.931 -- 00:00:56.191 are or may be considered forward-looking statements. 00:00:56.191 -- 00:01:01.417 Our Form 10-K for the 2025 fiscal year and our subsequent filings 00:01:01.417 -- 00:01:05.843 with the Securities and Exchange Commission identify certain factors that could cause 00:01:05.843 -- 00:01:10.808 our actual results to differ materially from those projected in any forward-looking statements 00:01:10.808 -- 00:01:15.834 made today. Our SEC filings, including the 10-K, are available on 00:01:15.834 -- 00:01:17.975 our website. 00:01:18.077 -- 00:01:22.743 We do not undertake to update any forward-looking statements as a result of new information 00:0...